InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Launches Rapid-Relief Migraine Treatments for Urgent Needs
Tonix Pharmaceuticals (NASDAQ: TNXP) through its subsidiary Tonix Medicines, has introduced two fast-acting migraine treatments, Zembrace® SymTouch® (sumatriptan autoinjector) and Tosymra® (sumatriptan nasal spray), aimed at providing relief within 10 minutes. Designed to meet the urgent needs of migraine sufferers who may experience attacks without warning, these non-oral options cater to individuals who wake with migraines or lack early warning signs. With this addition, Tonix…